Gan & Lee Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Gan & Lee (market cap of US$ 4bn) is the #1 domestic insulin supplier in China with 10 commercial products in 19 countries
- World-class E. coli fermentation system and leading purification technology
- Two mega-factories with a sufficient production capacity of 400 million biological finished products
- Multiple proprietary device/pen solutions available
- Focus on diabetes and obesity, multiple BIC assets are in clinical stages
- Early-stage research has expanded into oncology and autoimmune diseases (PROTAC and ADC)
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}